Its essential for healthy cognitive function
It acts as a dual agonist at amylin receptors (AMY1R, AMY2R, AMY3R, formed by calcitonin receptor heterodimerized with RAMP1-3) and calcitonin receptors, with structural modifications (e.g., N-terminal fatty acid acylation, proline substitutions) preventing fibril formation, enhancing stability, and enabling once-weekly dosing via albumin binding for prolonged circulation
Reduces inflammation and swelling, helping to alleviate pain and discomfort
authorities have started to crack down: FDA Warning on Safety Risks: In late 2023, the FDA explicitly flagged BPC-157 as an unsafe compound to use in compounding
What we do have is a coherent but indirect body of evidence